» Articles » PMID: 19343217

Variable Fitness Impact of HIV-1 Escape Mutations to Cytotoxic T Lymphocyte (CTL) Response

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2009 Apr 4
PMID 19343217
Citations 133
Authors
Affiliations
Soon will be listed here.
Abstract

Human lymphocyte antigen (HLA)-restricted CD8(+) cytotoxic T lymphocytes (CTL) target and kill HIV-infected cells expressing cognate viral epitopes. This response selects for escape mutations within CTL epitopes that can diminish viral replication fitness. Here, we assess the fitness impact of escape mutations emerging in seven CTL epitopes in the gp120 Env and p24 Gag coding regions of an individual followed longitudinally from the time of acute HIV-1 infection, as well as some of these same epitopes recognized in other HIV-1-infected individuals. Nine dominant mutations appeared in five gp120 epitopes within the first year of infection, whereas all four mutations found in two p24 epitopes emerged after nearly two years of infection. These mutations were introduced individually into the autologous gene found in acute infection and then placed into a full-length, infectious viral genome. When competed against virus expressing the parental protein, fitness loss was observed with only one of the nine gp120 mutations, whereas four had no effect and three conferred a slight increase in fitness. In contrast, mutations conferring CTL escape in the p24 epitopes significantly decreased viral fitness. One particular escape mutation within a p24 epitope was associated with reduced peptide recognition and high viral fitness costs but was replaced by a fitness-neutral mutation. This mutation appeared to alter epitope processing concomitant with a reduced CTL response. In conclusion, CTL escape mutations in HIV-1 Gag p24 were associated with significant fitness costs, whereas most escape mutations in the Env gene were fitness neutral, suggesting a balance between immunologic escape and replicative fitness costs.

Citing Articles

Functional variability of Nef in antagonizing SERINC5 during acute to chronic HIV-1 infection.

Li W, Li G, Liu Y, Meng L, Zhang T, Wang L AIDS. 2024; 39(3):229-240.

PMID: 39612239 PMC: 11784911. DOI: 10.1097/QAD.0000000000004079.


Insights to HIV-1 coreceptor usage by estimating HLA adaptation with Bayesian generalized linear mixed models.

Hake A, Germann A, De Beer C, Thielen A, Daumer M, Preiser W PLoS Comput Biol. 2023; 19(12):e1010355.

PMID: 38127856 PMC: 10769057. DOI: 10.1371/journal.pcbi.1010355.


Accelerating Bayesian inference of dependency between mixed-type biological traits.

Zhang Z, Nishimura A, Trovao N, Cherry J, Holbrook A, Ji X PLoS Comput Biol. 2023; 19(8):e1011419.

PMID: 37639445 PMC: 10491301. DOI: 10.1371/journal.pcbi.1011419.


Evolutionary implications of SARS-CoV-2 vaccination for the future design of vaccination strategies.

Rouzine I, Rozhnova G Commun Med (Lond). 2023; 3(1):86.

PMID: 37336956 PMC: 10279745. DOI: 10.1038/s43856-023-00320-x.


No Difference in the Prevalence of HIV-1 Cytotoxic T-Lymphocyte-Associated Escape Mutations in Viral Sequences from Early and Late Parts of the HIV-1 Subtype C Pandemic in Botswana.

Mokaleng B, Choga W, Bareng O, Maruapula D, Ditshwanelo D, Kelentse N Vaccines (Basel). 2023; 11(5).

PMID: 37243104 PMC: 10221913. DOI: 10.3390/vaccines11051000.


References
1.
Quinones-Mateu M, Ball S, Marozsan A, Torre V, Albright J, Vanham G . A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression. J Virol. 2000; 74(19):9222-33. PMC: 102121. DOI: 10.1128/jvi.74.19.9222-9233.2000. View

2.
Jones N, Wei X, Flower D, Wong M, Michor F, Saag M . Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response. J Exp Med. 2004; 200(10):1243-56. PMC: 2211924. DOI: 10.1084/jem.20040511. View

3.
Liu Y, McNevin J, Cao J, Zhao H, Genowati I, Wong K . Selection on the human immunodeficiency virus type 1 proteome following primary infection. J Virol. 2006; 80(19):9519-29. PMC: 1617227. DOI: 10.1128/JVI.00575-06. View

4.
Barouch D, Kunstman J, Glowczwskie J, Kunstman K, Egan M, Peyerl F . Viral escape from dominant simian immunodeficiency virus epitope-specific cytotoxic T lymphocytes in DNA-vaccinated rhesus monkeys. J Virol. 2003; 77(13):7367-75. PMC: 164797. DOI: 10.1128/jvi.77.13.7367-7375.2003. View

5.
Bhattacharya T, Daniels M, Heckerman D, Foley B, Frahm N, Kadie C . Founder effects in the assessment of HIV polymorphisms and HLA allele associations. Science. 2007; 315(5818):1583-6. DOI: 10.1126/science.1131528. View